We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

111 hedge funds and large institutions have $38.3M invested in Zomedica Corp. in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 17

4% more funds holding

Funds holding: 107 → 111 (+4)

0% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 22

0% less capital invested

Capital invested by funds: $38.5M → $38.3M (-$173K)

Holders
111
Holders Change
+4
Holders Change %
+3.74%
% of All Funds
1.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
22
Reduced
22
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$404K
2
BlackRock
BlackRock
New York
+$232K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$136K
4
HF
HRT Financial
New York
+$89.5K
5
SCA
Snowden Capital Advisors
New York
+$58.9K

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$3.28M
2
Nuveen
Nuveen
North Carolina
-$349K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$337K
4
UBS AM
UBS AM
Illinois
-$251K
5
CSS
Cubist Systematic Strategies
Connecticut
-$176K

ZOM Hedge Fund Activity: Q1 2022 in Review

111 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2022, worth a combined $38.3M — down 0.45% from $38.5M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new ZOM positions and 17 closed out — a net gain of 5 holders — while 22 added to existing stakes and 22 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $404K. The largest seller was State Street, cutting an estimated $3.28M.

  • 111 institutional investors held Zomedica Corp. (ZOM) as of Q1 2022, up from 107 in Q4 2021.
  • Funds reported $38.3M of Zomedica Corp. stock for Q1 2022, down 0.45% quarter-over-quarter.
  • 22 funds opened new Zomedica Corp. positions in Q1 2022 and 17 closed out, a net change of +5 holders.
  • The largest Zomedica Corp. buyer in Q1 2022 was Citadel Advisors, an estimated $404K added.
  • The largest Zomedica Corp. seller in Q1 2022 was State Street, an estimated $3.28M sold.

Based on aggregated 13F filings for Q1 2022.